Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR)
Latest Information Update: 08 Nov 2019
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis; Polymyalgia rheumatica; Takayasu syndrome
- Focus Therapeutic Use
- 26 Oct 2019 Results evaluating the efficacy and safety of tocilizumab monotherapy for newly diagnosed large vessel vasculitides published in the Rheumatology
- 24 Oct 2018 104-Week results (n=12) in patients with Large Vessel Vasculitis, presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 06 Mar 2017 Status changed from recruiting to active, no longer recruiting.